T0	Participants 167 216	levonorgestrel intrauterine contraceptive (LNG20)
T1	Participants 262 411	Nulliparous and parous women aged 16-45 years at enrollment with regular menstrual cycles and requesting contraception were enrolled in an open-label
T2	Participants 556 621	Women aged 36-45 years received LNG20 for safety evaluation only.
T3	Participants 729 887	total of 1600 women aged 16-35 years and 151 women aged 36-45 years agreed to LNG20 placement, including 1011 (57.7%) nulliparous and 438 (25.1%) obese women.
T4	Participants 888 940	Successful placement occurred in 1714 (97.9%) women.
T5	Participants 941 994	Six pregnancies occurred, four of which were ectopic.
T6	Participants 1336 1386	women who discontinued LNG20 and desired pregnancy
T7	Participants 1470 1486	10 (0.6%) women.
T8	Participants 1492 1507	26 (1.5%) LNG20
T9	Participants 1648 1677	nulliparous and parous women.